China Regenerative Medicine International Limited (8158) Announces Delay in Circular Dispatch

Bulletin Express
2025/11/21

China Regenerative Medicine International Limited (Stock Code: 8158) announced that the dispatch of a circular relating to its previously disclosed major transactions and breach of GEM Listing Rules will be delayed. The circular was initially scheduled for dispatch on or before 21 November 2025 and pertains to the Outstanding Payment Agreement, the Membership Transfer Agreements, and other related details.

The announcement specifies that additional time is needed to finalize information to be included in the circular. The company is therefore applying to the Stock Exchange for a waiver from strict compliance with the relevant GEM Listing Rules. It is currently expected that the dispatch date of the circular will be postponed to a date on or before 31 December 2025.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10